We value your privacy

This website or its third-party tools process personal data. You can opt out of the sale of your personal information by clicking on the “Do Not Sell or Share My Personal Information” link.

Powered by

Atacand

ACNU Feasibility

View full report
OKAtacand is an oral tablet ARB with serious fetal risks, notable side effects, and important drug interactions. It requires individualized dosing and close monitoring of blood pressure, kidney function, and potassium, with low misuse potential but moderate adherence challenges.

ACNU Feasibility Scorecard

Chart with 11 data points.
Atacand
The chart has 1 X axis displaying categories.
The chart has 1 Y axis displaying ← Lower is Better!. Data ranges from 1 to 8.
End of interactive chart.